drugset / Trial / NCT01565382

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

NCT01565382

Phase 3 Completed 40 enrolled Avid Radiopharmaceuticals
NaSingle-groupSingle-blindDiagnostic

Summary

Re-read of brain amyloid scans acquired in previous AV-45 clinical studies by readers trained using updated reading methodology. The scans in this study came from subjects who had Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI).

Timeline

Start
2011-02
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Background florbetapir F 18 Diagnostic / imaging agent 370 mbq Intravenous

Indications